Kowalchuk Roman O, Waters Michael R, Richardson K Martin, Spencer Kelly, Larner James M, McAllister William H, Sheehan Jason P, Kersh Charles R
1Radiosurgery Center, Riverside Regional Medical Center (in partnership with University of Virginia Health System), Newport News.
Departments of2Radiation Oncology and.
J Neurosurg Spine. 2020 Oct 23;34(2):267-276. doi: 10.3171/2020.6.SPINE20861. Print 2021 Feb 1.
This study evaluated a large cohort of patients treated with stereotactic body radiation therapy for spinal metastases and investigated predictive factors for local control, local progression-free survival (LPFS), overall survival, and pain response between the different spinal regions.
The study was undertaken via retrospective review at a single institution. Patients with a tumor metastatic to the spine were included, while patients with benign tumors or primary spinal cord cancers were excluded. Statistical analysis involved univariate analysis, Cox proportional hazards analysis, the Kaplan-Meier method, and machine learning techniques (decision-tree analysis).
A total of 165 patients with 190 distinct lesions met all inclusion criteria for the study. Lesions were distributed throughout the cervical (19%), thoracic (43%), lumbar (19%), and sacral (18%) spines. The most common treatment regimen was 24 Gy in 3 fractions (44%). Via the Kaplan-Meier method, the 24-month local control was 80%. Sacral spine lesions demonstrated decreased local control (p = 0.01) and LPFS (p < 0.005) compared with those of the thoracolumbar spine. The cervical spine cases had improved local control (p < 0.005) and LPFS (p < 0.005) compared with the sacral spine and trended toward improvement relative to the thoracolumbar spine. The 36-month local control rates for cervical, thoracolumbar, and sacral tumors were 86%, 73%, and 44%, respectively. Comparably, the 36-month LPFS rates for cervical, thoracolumbar, and sacral tumors were 85%, 67%, and 35%, respectively. A planning target volume (PTV) > 50 cm3 was also predictive of local failure (p = 0.04). Fewer cervical spine cases had disease with PTV > 50 cm3 than the thoracolumbar (p = 5.87 × 10-8) and sacral (p = 3.9 × 10-3) cases. Using decision-tree analysis, the highest-fidelity models for predicting pain-free status and local failure demonstrated the first splits as being cervical and sacral location, respectively.
This study presents a novel risk stratification for local failure and LPFS by spinal region. Patients with metastases to the sacral spine may have decreased local control due to increased PTV, especially with a PTV of > 50 cm3. Multidisciplinary care should be emphasized in these patients, and both surgical intervention and radiotherapy should be strongly considered.
本研究评估了一大群接受立体定向体部放射治疗脊柱转移瘤的患者,并调查了不同脊柱区域局部控制、局部无进展生存期(LPFS)、总生存期和疼痛反应的预测因素。
本研究通过在单一机构进行回顾性审查开展。纳入脊柱有肿瘤转移的患者,排除患有良性肿瘤或原发性脊髓癌的患者。统计分析包括单因素分析、Cox比例风险分析、Kaplan-Meier方法和机器学习技术(决策树分析)。
共有165例患者的190个不同病灶符合本研究的所有纳入标准。病灶分布于颈椎(19%)、胸椎(43%)、腰椎(19%)和骶椎(18%)。最常见的治疗方案是分3次给予24 Gy(44%)。通过Kaplan-Meier方法,24个月的局部控制率为80%。与胸腰椎病灶相比,骶椎病灶的局部控制率(p = 0.01)和LPFS(p < 0.005)降低。与骶椎相比,颈椎病例的局部控制率(p < 0.005)和LPFS(p < 0.005)有所改善,且相对于胸腰椎有改善趋势。颈椎、胸腰椎和骶椎肿瘤的36个月局部控制率分别为86%、73%和44%。同样,颈椎、胸腰椎和骶椎肿瘤的36个月LPFS率分别为85%、67%和35%。计划靶体积(PTV)> 50 cm³也可预测局部失败(p = 0.04)。颈椎病例中PTV> 50 cm³的疾病比胸腰椎(p = 5.87×10⁻⁸)和骶椎(p = 3.9×10⁻³)病例少。使用决策树分析,预测无痛状态和局部失败的最高保真模型显示首次分割分别为颈椎和骶椎位置。
本研究提出了一种按脊柱区域对局部失败和LPFS进行的新型风险分层。骶椎转移患者可能由于PTV增加而导致局部控制降低,尤其是PTV> 50 cm³时。应强调对这些患者进行多学科护理,同时应强烈考虑手术干预和放疗。